Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Endometrial Adenocarcinoma × Trastuzumab × Clear all

Sponsor

Conditions

Breast Neoplasms 208 Stomach Neoplasms 17 Neoplasm Metastasis 13 Breast Neoplasms, Male 13 Neoplasms 8 Esophageal Neoplasms 8 Brain Neoplasms 7 Inflammatory Breast Neoplasms 6 Colorectal Neoplasms 4 Adenocarcinoma Of Esophagus 4 Triple Negative Breast Neoplasms 3 Urologic Neoplasms 2 HER2-positive Breast Cancer 2 Gallbladder Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Intraductal, Noninfiltrating 2 Carcinoma, Ductal, Breast 2 Adenocarcinoma 2 Urinary Bladder Neoplasms 1 Solid Cancers 1 Rectal Neoplasms 1 Patient Preference 1 Patient Compliance 1 Osteitis Deformans 1 Neoplasm, Residual 1 Meningeal Neoplasms 1 Malignant Solid Neoplasm 1 Locally Advanced Breast Cancer 1 Lethal Congenital Contracture Syndrome 2 1 Hormone Receptor Positive Breast Cancer 1

Interventions

Taxes 3 Paclitaxel 3 Carboplatin 2 temsirolimus 1 pegfilgrastim 1 nintedanib 1 ixabepilone 1 cediranib 1 brivanib 1 Sunitinib 1 Sirolimus 1 Medroxyprogesterone Acetate 1 Medroxyprogesterone 1 MK 2206 1 Immunoglobulin G 1 Granulocyte Colony-Stimulating Factor 1 Gemcitabine 1 Filgrastim 1 Epothilones 1 Doxorubicin 1 Disulfides 1 Cisplatin 1 Brachytherapy 1 Bevacizumab 1 ALK1-Fc fusion protein, human 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡